Intelligent Bio Solutions Secures ISO Recertification, Aligning With New FDA QMSR

Intelligent Bio Solutions (INBS) announced recertification of its Intelligent Fingerprinting Drug Screening business under the ISO 13485:2016 quality management system standard, with certification issued by the British certifying body (article text truncated). The update supports continued regulatory/quality compliance for the company’s medical technology operations, but is not likely to materially move the stock.

Analysis

Intelligent Bio Solutions (INBS) announced recertification of its Intelligent Fingerprinting Drug Screening business under the ISO 13485:2016 quality management system standard, with certification issued by the British certifying body (article text truncated). The update supports continued regulatory/quality compliance for the company’s medical technology operations, but is not likely to materially move the stock.